================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------
SCHEDULE TO/A
(Amendment No. 3)
(Rule 14d-100)
Tender Offer Statement Under Section
14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934
ALARIS MEDICAL SYSTEMS, INC.
(Name of Subject Company--Issuer)
BLUE MERGER CORP.,
a wholly owned subsidiary of
CARDINAL HEALTH, INC.
(Name of Filing Persons--Offerors)
COMMON STOCK, PAR VALUE $0.01 PER SHARE
(Title of Class of Securities)
011637105
(CUSIP Number of Class of Securities)
Paul S. Williams
Executive Vice President, Chief Legal Officer and Secretary
Cardinal Health, Inc.
7000 Cardinal Place
Dublin, Ohio 43017
Telephone: (614) 757-5000
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications on Behalf of Filing Persons)
Copy To:
David A. Katz, Esq.
Wachtell, Lipton, Rosen & Katz
51 West 52nd Street
New York, New York 10019
Telephone: (212) 403-1000
[_] Check the box if any part of the fee is offset as provided by Rule
0-11(a)(2) and identify the filing with which the offsetting fee was
previously paid. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing. Amount
Previously Paid: None. Filing Party: Not applicable. Form or Registration
No.: Not applicable. Date Filed: Not applicable.
[_] Check the box if the filing relates solely to preliminary communications
made before the commencement of a tender offer. Check the appropriate boxes
below to designate any transactions to which the statement relates:
[X] third-party tender offer subject to Rule 14d-1.
[_] issuer tender offer subject to Rule 13e-4.
[_] going-private transaction subject to Rule 13e-3.
[X] amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the results
of the tender offer: [_]
================================================================================
This Amendment No. 3 (the "Amendment") amends and supplements the
Tender Offer Statement on Schedule TO (the "Schedule TO"), filed initially with
the Securities and Exchange Commission (the "Commission") on May 28, 2004 by
Cardinal Health, Inc., an Ohio corporation ("Cardinal Health"), and Blue Merger
Corp., a Delaware corporation and a wholly owned subsidiary of Cardinal Health
("Subcorp"), as amended by Amendment No. 1 filed with the Commission on June 1,
2004 and Amendment No. 2 transmitted for filing with the Commission on June 14,
2004, relating to the offer by Subcorp to purchase all outstanding shares of
common stock, par value $0.01 per share (the "Shares"), of ALARIS Medical
Systems, Inc., a Delaware corporation ("ALARIS"), for $22.35 per Share, net to
the seller in cash, upon the terms and subject to the conditions set forth in
the Offer to Purchase, dated May 28, 2004 (the "Offer to Purchase"), and in the
related Letter of Transmittal, copies of which were filed previously with the
Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively (which, together
with any amendments or supplements to the Offer to Purchase and the Letter of
Transmittal, collectively constitute the "Offer").
ITEM 11. ADDITIONAL INFORMATION
Item 11 of the Schedule TO is hereby amended and supplemented by the
following:
On June 22, 2004, the German Federal Cartel Office granted early
termination of the applicable waiting period under Germany's Act against
Restrictions of Competition.
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Schedule TO is true, complete and
correct.
Dated: June 22, 2004
BLUE MERGER CORP.
By: /s/ PAUL S. WILLIAMS
------------------------
NAME: PAUL S. WILLIAMS
TITLE: EXECUTIVE VICE PRESIDENT, CHIEF
LEGAL OFFICER AND SECRETARY
CARDINAL HEALTH, INC.
By: /s/ PAUL S. WILLIAMS
------------------------
NAME: PAUL S. WILLIAMS
TITLE: EXECUTIVE VICE PRESIDENT, CHIEF
LEGAL OFFICER AND SECRETARY